FDA Approved: INVOKANA — Supplemental Application (Janssen Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for INVOKANA (canagliflozin) submitted by Janssen Pharmaceuticals, resulting in updated labeling for the product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• INVOKANA (CANAGLIFLOZIN)

Snippet

SUPPL AP for INVOKANA (CANAGLIFLOZIN)